This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, which is in Phase II clinical trial for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd.
Show more...
CEO
Employees
579
Country
BM
ISIN
BMG637AM1024
WKN
000A2DFYA
Listings
0 Comments
Share your thoughts
FAQ
What is Myovant Sciences stock price today?▼
The current price of MYOV is $26.98 USD — it has decreased by -0.04% in the past 24 hours. Watch Myovant Sciences stock price performance more closely on the chart.
What is Myovant Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Myovant Sciences stocks are traded under the ticker MYOV.
What is Myovant Sciences market cap?▼
Today Myovant Sciences has the market capitalization of 2.61B
What is Myovant Sciences revenue for the last year?▼
Myovant Sciences revenue for the last year amounts to 230.97M USD.
What is Myovant Sciences net income for the last year?▼
MYOV net income for the last year is -205.98M USD.
How many employees does Myovant Sciences have?▼
As of April 03, 2026, the company has 579 employees.
In which sector is Myovant Sciences located?▼
Myovant Sciences operates in the Manufacturing sector.
When did Myovant Sciences complete a stock split?▼
Myovant Sciences has not had any recent stock splits.